176750 — Duchembio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩264bn
Enterprise Value
KR₩273bn
Revenue
KR₩39bn

Annual balance sheet for Duchembio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,166	2,594	1,970	10,690	15,450
Net Total Accounts Receivable
Net Total Receivables	7,852	8,868	9,103	10,181	12,121
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10,453	12,331	12,668	22,240	28,957
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26,995	17,978	16,186	16,712	22,954
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	59,986	51,351	49,277	65,168	77,676
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30,196	24,187	19,357	14,925	18,381
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	39,132	33,757	27,482	22,159	28,436
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	20,854	17,594	21,794	43,010	49,240
Total Liabilities & Shareholders' Equity	59,986	51,351	49,277	65,168	77,676
Total Common Shares Outstanding